Psychedelic-assisted therapy (PAT) represents one of the most promising developments in psychiatry in decades. The treatment typically involves the infusion of a compound such as LSD, psilocybin, or MDMA during an extended therapy session with licensed professionals. Although it lacks widespread regulatory approval or clinical use, significant advances have been made in the study of
Prudence and promise in psychedelic-assisted therapy originally appeared in KevinMD.com.
